The PIK3CA gene gives cells instructions for a protein that helps control growth, survival, and how cells respond to signals. When this gene becomes too active because of a variant, cells can keep growing when they should not, which can contribute to several cancers and some body overgrowth conditions. Some people first learn about this gene when breast cancer testing finds a PIK3CA variant that may help guide treatment. It is well known in cancer medicine, but its effects depend on the exact variant and where it is found in the body.
What is a gene?
Genes are stretches of DNA that give your cells instructions to make molecules or to direct processes in the body. Some genes carry the code for proteins, the parts of cells that do much of the work. Other genes mostly regulate when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in LearnHub.
Overview
PIK3CAGene function
What if the gene works
The PIK3CA gene helps cells respond to growth signals. Its protein supports controlled cell growth, survival, movement, and energy use.
Risk
What if the gene does not work
Activating variants in the PIK3CA gene can cause patchy body overgrowth and blood vessel changes, and they are also common in many cancers. Effects can range from mild to more extensive depending on the variant and when it arises.
Treatment
What does that mean for your treatment
Certain pathogenic variants in the PIK3CA gene, usually activating rather than loss-of-function, can affect treatment choices. In current guidelines, they can make some people eligible for the PI3K inhibitor alpelisib in specific settings, such as some hormone receptor positive, HER2 negative advanced breast cancers, usually with endocrine therapy. Alpelisib is also used for some people with PIK3CA related overgrowth.
Conditions associated with PIK3CA
Gene function
What if the gene works
Growth and energy signals are moving through your cells all the time. The PIK3CA gene helps carry those messages inward, especially after cues such as insulin. This supports everyday cell growth, fuel use, and survival. This is part of how the PIK3CA gene works in the body each day.
The PIK3CA gene helps cells pass along messages from insulin and other growth signals at the cell surface. This lets cells adjust their activity to match the body’s needs.
Inside the cell membrane, this gene helps make a small signal from membrane fat that turns on the next steps. That signal carries the message from the cell surface deeper into the cell.
By relaying these messages, the PIK3CA gene supports normal cell growth, division, and survival. It helps cells respond in a controlled way to everyday cues from the body.
This pathway helps cells respond to insulin when they take in and use glucose (blood sugar). That makes the PIK3CA gene part of normal day to day energy handling in many tissues.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Most disease-linked changes in the PIK3CA gene are activating variants that keep the protein partly switched on, showing how PIK3CA variants affect cell growth signaling. This can make cells send stronger growth and survival signals than usual. Some variants raise signaling only modestly, while others drive it more strongly, which can influence how early changes appear and how extensive they become. Different tissues may also be affected depending on when the variant arises.
How variants are linked to conditions
Pathogenic variants in the PIK3CA gene can cause PIK3CA-related overgrowth spectrum, which includes CLOVES syndrome and related overgrowth conditions. These variants may also be linked to isolated overgrowth or vascular malformations present from birth. Separate, acquired variants in the PIK3CA gene are common in some tumors, especially breast cancer, and are also seen in colorectal and endometrial cancers.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the PIK3CA gene itself. For many living with a PIK3CA-related condition, risk is mainly shaped by the genetic change and where it is present in the body, rather than by lifestyle factors.
Inheritance of PIK3CA variants
How are variants of the PIK3CA gene inherited? The pattern depends on the condition and on whether the variant is present in all cells or only some of them. When a disease causing change in the PIK3CA gene is present from conception, it follows an autosomal dominant pattern, so an affected parent can pass it on with a 50% chance in each pregnancy. Many PIK3CA-related overgrowth conditions happen because of a new variant that arises after conception in only some cells, called mosaicism, so they are usually not inherited from either parent and often are not passed on.
What does my PIK3CA result mean for my family?
There is not a broadly confirmed family inheritance pattern for PIK3CA tied to one specific inherited condition. Many PIK3CA-related findings happen after conception, so they are often not passed down through families in the usual way. If you have a specific PIK3CA result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of that exact result.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for PIK3CA variants may use blood, saliva, cheek cells, tumor tissue, or affected skin, depending on the reason for testing. A lab reads the DNA sequence of the PIK3CA gene to look for a variant. Some PIK3CA variants are easier to find in the affected tissue than in blood.
When should I consider getting a genetic test?
Genetic testing for the PIK3CA gene may be worth discussing if you or your child has unusual body overgrowth, one side larger than the other, or certain blood vessel birthmarks, especially from birth or early childhood. It can also be considered when tumor testing finds a PIK3CA change, to help clarify what it means.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but the amount it explains varies with the condition and the kind of variant involved. Over time, many factors such as lifestyle, environment, age, and medical history also influence how the body functions. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
In some cancers, variants in the PIK3CA gene can help predict response to targeted treatment such as alpelisib, because this medicine is designed to block the overactive cell growth signal linked to that gene change. This means two people with the same cancer type may respond differently if one tumor carries a PIK3CA variant and the other does not. Genetic differences like this are common and can affect how well a treatment works or how sensitive someone is to side effects. In this setting, the key gene change is usually found in the tumor itself rather than inherited through the family.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how differences in genes affect the way people respond to medications. It explores links between genes and drugs to help explain why the same treatment can work differently in different people. With many medicines, genes can influence both how strong a drug’s effects are and how the body handles it. This information can support treatment decisions that are more informed and more individualized. To learn more about this topic, you can visit the LearnHub.
Drugs influenced by the PIK3CA gene
When should I seek medical advice?
If you are being treated for cancer, talk with your cancer doctor before starting or changing treatment, because PIK3CA changes in the tumor can help guide the use of some targeted medicines. This matters most in certain breast cancers, where a PIK3CA result may affect treatment options.
History
The PIK3CA gene entered cancer research as scientists mapped growth signaling pathways in the late 20th century. In 1997, researchers identified PIK3CA as the gene for a key part of phosphoinositide 3 kinase, often shortened to PI3K. Building on this early work, scientists uncovered more about the gene when large tumor studies in the early 2000s showed that PIK3CA variants are among the most common genetic changes in several cancers. This helped establish the PI3K pathway as a major focus in cancer biology. Over time, descriptions became more precise as researchers linked specific PIK3CA variants with particular tumor types and treatment responses. Today, the gene is widely recognized as an important milestone in the shift toward more genetics-guided cancer care.